Work overview

Section 05 of 05

Conclusion

Reduced IQGAP2 promotes esophageal squamous cell carcinoma by regulating MEK/ERK MAPK pathway

Liangcheng Zhao · 2026

Contents

Section 05 of 05

  1. 01Introduction
  2. 02Materials and methods
  3. 03Results
  4. 04Discussion
  5. 05Conclusion
Text size
Work overview

Section 5 of 5

Conclusion

Liangcheng Zhao · about 1 minutes

Original source ↗

In summary, this study contributes novel insights into the tumor suppressive functions of IQGAP2 in ESCC through modulation of the MEK/ERK MAPK pathway (Figure 5). Our findings extend the growing body of literature identifying IQGAP2 as a critical regulator of tumorigenesis and provide a rationale for further investigation of IQGAP2 as a therapeutic target in ESCC.

FIGURE 5: Diagram illustrating that reduced IQGAP2 in ESCC cells leads to activation of MEK and ERK signaling, increasing cell proliferation and contributing to ESCC progression, shown by multiple proliferating cells.

FIGURE 5: Schematic diagram indicates the proposed role of IQGAP2 in ESCC. Reduced IQGAP2 promotes ESCC cell proliferation via MEK/ERK MAPK pathway.